Ophthalmology News and Research RSS Feed - Ophthalmology News and Research

Community efforts boost people for HIV testing and reduce new infections

Community efforts boost people for HIV testing and reduce new infections

Communities in Africa and Thailand that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study in the peer-reviewed journal The Lancet Global Health. [More]
Analysis of Medicare pay shows variations in drugs used and earnings by specialists

Analysis of Medicare pay shows variations in drugs used and earnings by specialists

The Washington Post examines how drugs administered by doctors is different in various regions of the country. Other outlets look at other issues, including how eye doctors are among the highest paid specialty. [More]

First Edition: April 10, 2014

Today's headlines include a range of stories taking additional looks at the Medicare physician payment data released yesterday by the Centers for Medicare & Medicaid Services. [More]
Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China. [More]
Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences. A case report published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) describes cardiopulmonary arrest in a 27-week-old infant following administration of three sets of cyclopentolate 0.2%/phenylephrine 1% (Cyclomydril) eyedrops. [More]

Richard L. Abbott receives 2014 International Duke Elder Medal at World Ophthalmology Conference

Richard L. Abbott, M.D., secretary for Global Alliances for the American Academy of Ophthalmology – the world's largest association of eye physicians and surgeons – today received the 2014 International Duke Elder Medal at the opening ceremony of the World Ophthalmology Conference in Tokyo. [More]
Leica Microsystems and TrueVision 3D Surgical expand relationship into the ophthalmology arena

Leica Microsystems and TrueVision 3D Surgical expand relationship into the ophthalmology arena

TrueVision 3D Surgical, a world leader in neuro and ophthalmic 3D surgical visualization, and Leica Microsystems, a world leader in microscopes and scientific instruments, announced an expansion of their existing partnership into the ophthalmology arena. [More]
Actavis announces acquisition of Silom Medical for $100 million

Actavis announces acquisition of Silom Medical for $100 million

Actavis plc, a leading global specialty pharmaceutical company today announced that it has acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand, for approximately $100 million in cash. [More]

New report reveals potential breakthrough in pterygium treatment

A new report reveals a potential breakthrough in the treatment of a common eye ailment known as pterygium (Surfer's eye) that impacts the vision, eye health, and cosmetic appearance of countless sufferers. [More]

BioLight seeks FDA IND approval for subconjunctival Latanoprost controlled release insert Phase I/IIa study

BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a Phase I/IIa clinical study with its subconjunctival Latanoprost controlled release insert for the treatment of glaucoma. [More]
Research report on global ophthalmology devices market

Research report on global ophthalmology devices market

The "Ophthalmology Devices Market (Optical Coherence Tomography (OCT) Scanner, Fundus Camera, Tonometer, Pachymeter, Perimeter, Slit Lamp, Excimer, YAG Laser, Femtosecond Laser, IOL, Contact Lens) - Competitive Landscape & Global Forecasts to 2018", published by MarketsandMarkets, the ophthalmology devices market inclusive of diagnostic, monitoring and surgical devices is expected to grow at a CAGR of 6.8% to reach $9,466.7 Million by 2018. [More]
Research may lead the way toward new treatments for proliferative retinopathies

Research may lead the way toward new treatments for proliferative retinopathies

A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies). Specifically, scientists have discovered that the body's innate immune system does more than help ward off external pathogens. [More]

Tips to avoid eye irritation and longer-term damage to eyes during allergy season

With the advent of spring comes wind and allergy season, which can prove to be challenging for individuals who rely on contact lenses for clearer vision. According to the Asthma and Allergy Foundation of America, approximately 1 out of 5 individuals in the United States suffer from eye allergies, while nearly half of all individuals who wear contact lenses report irritation and discomfort from wearing contacts during allergy season. [More]
SIFI, NovaMedica agree to market eight products for treatment of ophthalmic pathologies in Russia

SIFI, NovaMedica agree to market eight products for treatment of ophthalmic pathologies in Russia

Leading Italian developer of innovative eye care solutions S.I.F.I. S.p.A. and Russian pharmaceutical company NovaMedica have entered into an exclusive commercial agreement for NovaMedica to market eight products developed and licensed by SIFI for the treatment of a wide range of ophthalmic pathologies in Russia and the CIS. [More]
Researchers discover novel population of neutrophils that exhibit enhanced microbial killing activity

Researchers discover novel population of neutrophils that exhibit enhanced microbial killing activity

​Case Western Reserve University researchers have discovered a novel population of neutrophils, which are the body's infection control workhorses. These cells have an enhanced microbial killing ability and are thereby better able to control infection. [More]

AMRI signs definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals

AMRI today announced that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals, Inc. for $38.2 million in cash. [More]
Occasional drinking and physically activity linked with reduced risk of developing visual impairment

Occasional drinking and physically activity linked with reduced risk of developing visual impairment

A physically active lifestyle and occasional drinking are associated with a reduced risk of developing visual impairment, according to a study published online this month in Ophthalmology, the journal of the American Academy of Ophthalmology. [More]

Study suggests that screening children for retinoblastoma may not improve outcomes for majority of patients

For the most common form of childhood eye cancer, unilateral retinoblastoma, shortening the time from the first appearance of symptoms to diagnosis of disease has no bearing on survival or stage of the disease, according to a study by researchers at Columbia University Mailman School of Public Health in partnership with the Hospital Infantil de Mexico. [More]
Eye abnormalities may help reveal features of early-stage Alzheimer's disease, says study

Eye abnormalities may help reveal features of early-stage Alzheimer's disease, says study

​Investigators at the Cedars-Sinai Regenerative Medicine Institute have discovered eye abnormalities that may help reveal features of early-stage Alzheimer's disease. Using a novel laboratory rat model of Alzheimer's disease and high-resolution imaging techniques, researchers correlated variations of the eye structure, to identify initial indicators of the disease. [More]
Building muscle mass important in decreasing metabolic risk

Building muscle mass important in decreasing metabolic risk

New UCLA research suggests that the more muscle mass older Americans have, the less likely they are to die prematurely. The findings add to the growing evidence that overall body composition - and not the widely used body mass index, or BMI - is a better predictor of all-cause mortality. [More]